Trial Profile
A phase III open-label study of the efficacy and safety of ARD-0403, a testosterone cream, in testosterone deficient men
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Feb 2008
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- 15 Feb 2008 Status changed from recruiting to completed, in accordance with clinicaltrials.gov.
- 17 May 2007 New trial record.